(Q74778934)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664784%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

review article

1 reference

title

Psychopharmacologic treatment of depression in the medically ill (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664784%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

Beliles K

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664784%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Stoudemire A

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664784%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 May 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664784%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664784%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664784%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664784%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

S2-19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664784%20AND%20SRC:MED&resulttype=core&format=json

Somatic presentation of DSM III psychiatric disorders in primary care.

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Prevalence by Self-report questionnaire and recognition by nonpsychiatric physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Assessing depression in primary medical and psychiatric practices.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

The epidemiology of depression in medical care

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Carbamazepine but not valproate induces bupropion metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Tricyclic antidepressants in depressed patients with cardiac conduction disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Use of cyclic antidepressants in patients with cardiac conduction disturbances

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

A Review of the Cardiovascular Effects and Toxicity of Tricyclic Antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Cardiovascular effects of bupropion in depressed patients with heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Psychoses associated with bupropion treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Effect of paroxetine on the electrocardiogram

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

New antidepressant drugs and the treatment of depression in the medically ill patient

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Effects of a controlled-release formulation of trazodone on psychomotor and autonomic functions in healthy volunteers: Comparison with trazodone (conventional formulation), amitriptyline and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Fluoxetine impairs clearance of alprazolam but not of clonazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Age, sex, and nitrazepam kinetics: relation to antipyrine disposition.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Effect of age and liver cirrhosis on the pharmacokinetics of nitrazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

The effect of fluoxetine on warfarin metabolism in the rat and man

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Abnormal platelet aggregation associated with fluoxetine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

The role of psychiatric factors in symptoms of hiatus hernia or gastric reflux

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Effects of desipramine on irritable bowel syndrome compared with atropine and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Antidepressants for functional gastrointestinal syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Lack of interaction of ranitidine with amitriptyline

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Psychopharmacology in patients with renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Tricyclic antidepressant and metabolite levels in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Fluoxetine kinetics and protein binding in normal and impaired renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Breath 14CO2 after intravenous administration of [14C]aminopyrine in liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Effects of aging and liver disease on disposition of lorazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Pharmacokinetics of paroxetine in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Pharmacokinetics of fluvoxamine maleate in patients with liver cirrhosis after single-dose oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Second generation antidepressants: a comparative review

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Sleep disorders on a psychiatric consultation service.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Severe daytime somnolence in patients treated with an MAOI.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Dyskinesia associated with fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Fluoxetine, fluvoxamine and extrapyramidal tract disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Extrapyramidal symptoms in a patient treated with fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Fluoxetine and side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

Increase of Parkinson disability after fluoxetine medication

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

1 reference

7 January 2021

Clinical Implications of the Pharmacology of Sertraline

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2898%2971339-8

7 January 2021

10.1016/S0033-3182(98)71339-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9664784%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference